Rocket Lab USA (RKLB)
(Real Time Quote from BATS)
$3.65 USD
-0.03 (-0.82%)
Updated Apr 24, 2024 01:38 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Balance Sheet
Fiscal Year End for Rocket Lab USA, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 245 | 472 | 691 | 1 | -99,999 |
Receivables | 35 | 37 | 14 | 0 | NA |
Notes Receivable | 0 | 0 | 0 | 0 | NA |
Inventories | 108 | 92 | 48 | 0 | NA |
Other Current Assets | 89 | 62 | 22 | 0 | NA |
Total Current Assets | 477 | 662 | 775 | 1 | NA |
Net Property & Equipment | 145 | 102 | 65 | 0 | NA |
Investments & Advances | 79 | 9 | 0 | 0 | NA |
Other Non-Current Assets | 0 | 0 | 0 | 0 | NA |
Deferred Charges | 4 | 4 | 6 | 0 | NA |
Intangibles | 139 | 151 | 101 | 0 | NA |
Deposits & Other Assets | 23 | 11 | 6 | 320 | NA |
Total Assets | 941 | 989 | 981 | 321 | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | NA |
Accounts Payable | 29 | 12 | 3 | 0 | NA |
Current Portion Long-Term Debt | 18 | 3 | 3 | 0 | NA |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | NA |
Accrued Expenses | 6 | 9 | 11 | 0 | NA |
Income Taxes Payable | 0 | 0 | 0 | 0 | NA |
Other Current Liabilities | 171 | 139 | 79 | 11 | NA |
Total Current Liabilities | 223 | 163 | 96 | 11 | NA |
Mortgages | 0 | 0 | 0 | 0 | NA |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | NA |
Convertible Debt | 0 | 0 | 0 | 0 | NA |
Long-Term Debt | 88 | 100 | 97 | 0 | NA |
Non-Current Capital Leases | 15 | 16 | 0 | 0 | NA |
Other Non-Current Liabilities | 4 | 3 | 60 | 305 | NA |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | NA |
Total Liabilities | 387 | 316 | 282 | 316 | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | NA |
Common Stock (Par) | 0 | 0 | 0 | 0 | NA |
Capital Surplus | 1,176 | 1,113 | 1,002 | 5 | NA |
Retained Earnings | -624 | -441 | -305 | 0 | NA |
Other Equity | 2 | 1 | 1 | 0 | NA |
Treasury Stock | 0 | 0 | 0 | 0 | NA |
Total Shareholder's Equity | 555 | 673 | 698 | 5 | NA |
Total Liabilities & Shareholder's Equity | 941 | 989 | 981 | 321 | NA |
Total Common Equity | 555 | 673 | 698 | 5 | 0 |
Shares Outstanding | 48.80 | 475.30 | 450.10 | 9.50 | NA |
Book Value Per Share | 11.36 | 1.42 | 1.55 | 0.53 | 0.00 |
Fiscal Year End for Rocket Lab USA, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 245 | 288 | 341 | 399 |
Receivables | NA | 35 | 23 | 25 | 51 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 108 | 102 | 102 | 98 |
Other Current Assets | NA | 89 | 93 | 92 | 87 |
Total Current Assets | NA | 477 | 506 | 560 | 635 |
Net Property & Equipment | NA | 145 | 136 | 120 | 96 |
Investments & Advances | NA | 79 | 82 | 74 | 48 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 4 | 3 | 4 | 4 |
Intangibles | NA | 139 | 141 | 144 | 148 |
Deposits & Other Assets | NA | 23 | 22 | 16 | 10 |
Total Assets | NA | 941 | 950 | 982 | 991 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 29 | 25 | 26 | 23 |
Current Portion Long-Term Debt | NA | 18 | 105 | 104 | 3 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 6 | 6 | 6 | 9 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 171 | 168 | 169 | 163 |
Total Current Liabilities | NA | 223 | 304 | 306 | 197 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 88 | 0 | 0 | 101 |
Non-Current Capital Leases | NA | 15 | 15 | 15 | 15 |
Other Non-Current Liabilities | NA | 4 | 6 | 3 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 387 | 365 | 370 | 351 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 1,176 | 1,161 | 1,145 | 1,126 |
Retained Earnings | NA | -624 | -573 | -532 | -487 |
Other Equity | NA | 2 | -2 | -2 | 1 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 555 | 586 | 611 | 640 |
Total Liabilities & Shareholder's Equity | NA | 941 | 950 | 982 | 991 |
Total Common Equity | 0 | 555 | 586 | 611 | 640 |
Shares Outstanding | 489.10 | 48.80 | 485.80 | 482.60 | 478.10 |
Book Value Per Share | 0.00 | 11.36 | 1.21 | 1.27 | 1.34 |